Peripheral Blood Mononuclear Cell (PBMC) is a key component of the immune system and are therefore used as the most fundamental experimental material in immunology, immunomics, infectious diseases, malignancies, vaccine development, transplantation therapy, personalized medicine, and toxicology. CD Genomics provides professional PBMC isolation services to clients worldwide to advance immunomics projects.
PBMC refers to cells in the peripheral blood that have a single nucleus, including lymphocytes, monocytes, dendritic cells (DC), and a small number of other cells. The proportion of different subtypes in PBMC varies from person to person, but on average, lymphocytes make up the majority of PBMC (70%-90%). In addition, PBMC contains a small proportion of dendritic cells (1-2%), which form an important bridge between the innate and adaptive immune systems.
Peripheral blood is the place of exposure to chemicals making PBMC susceptible to the effects of drugs and chemicals. This is why the availability of peripheral blood PBMC is so important to researchers studying the toxicity of new drugs or compounds. PBMC has been used extensively to assess several aspects of immune regulation.
PBMC is isolated from peripheral blood by density gradient centrifugation. Density gradient centrifugation, more widely known as isopycnic centrifugation, is a technique in which macromolecules move through a density gradient until they find the same density as their own. The most common layering solutions used in PBMC isolation include Ficoll and Percoll.
PBMCs are a key component of the immune system. Similarly, the PBMC transcriptional profile is an important component of immunohistology. The study of PBMC is of great importance to facilitate disease modeling, drug toxicity screening, drug discovery, and personalized medicine with cell replacement therapy.
CD Genomics has been dedicated to immunomics research for many years and has accumulated a wealth of experience. For your special projects, CD Genomics offers PBMC isolation from the peripheral blood of human, non-human primates, mice, and rats to generate reliable experimental materials for your immunomics projects.
![]() |
High Purity: the purity of the obtained cells reaches (90%-99%). |
![]() |
Great Yield: the obtained rate is up to 90%. |
![]() |
Low Impact on Cell Viability: the rate of viable cells is greater than 95%. |
CD Genomics is a pioneer in immunomics research. We are committed to advancing the convergence of omics and immunology to provide premium solutions for your projects. Please contact us for more information.